OTCPK:RAONF (Australia)  
Race Oncology Ltd logo

Race Oncology Ltd

$ 1.45 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
7.92
Market Cap:
$ 229.43M
Enterprise V:
$ 203.39M
Volume:
-
Avg Vol (2M):
2.80K
Also Trade In:
Volume:
-
Market Cap $:
229.43M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.80K
Enterprise Value $:
203.39M
PB Ratio:
7.92
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Race Oncology Ltd
1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000
Description
Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.98
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -44.23
12-1 Month Momentum % -46.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 49.05
Quick Ratio 49.05
Cash Ratio 47.2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.8
Name Current Vs Industry Vs History
ROE % -42.37
ROA % -41.46
ROIC % -234.74
ROC (Joel Greenblatt) % -2187.02
ROCE % -45.75

Financials

RAONF's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:RAONF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.048
Beta 0
Volatility % 44.45
14-Day RSI 0
14-Day ATR ($) 0.007668
20-Day SMA ($) 1.45
12-1 Month Momentum % -46.1
52-Week Range ($) 1.45 - 3.12
Shares Outstanding (Mil) 159.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Race Oncology Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More